Consequently, lower PCSK9 expression potentially provides HCC with a preferential phenotype to utilize cholesterol: higher expression of LDLR in the tumor as compared to the areas surrounding the tumor would increase LDL internalisation in the tumor, making LDL more available to the cancer cells and facilitating cholesterol availability to HCC. This evidence concerns the gene PCSK9 and cancer.